Your browser doesn't support javascript.
loading
A systematic review and meta-analysis of HCV clearance.
Gauthiez, Emeline; Habfast-Robertson, Ines; Rüeger, Sina; Kutalik, Zoltan; Aubert, Vincent; Berg, Thomas; Cerny, Andreas; Gorgievski, Meri; George, Jacob; Heim, Markus H; Malinverni, Raffaele; Moradpour, Darius; Müllhaupt, Beat; Negro, Francesco; Semela, David; Semmo, Nasser; Villard, Jean; Bibert, Stéphanie; Bochud, Pierre-Yves.
Afiliação
  • Gauthiez E; Infectious Diseases Service, Department of Medicine, University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Habfast-Robertson I; Faculty of Medicine, University of Lausanne, Lausanne, Switzerland.
  • Rüeger S; Institute for Social and Preventive Medicine and Department of Medical Genetics, University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Kutalik Z; Institute for Social and Preventive Medicine and Department of Medical Genetics, University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Aubert V; Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
  • Berg T; Department of Hepatology, Universitätsklinikum Leipzig, Leipzig, Germany.
  • Cerny A; Epatocentro Ticino, Lugano, Switzerland.
  • Gorgievski M; Division of Infectious Diseases, University Hospital of Bern, Bern, Switzerland.
  • George J; Storr Liver Centre, Westmead Millennium Institute, University of Sydney and Westmead Hospital, Sydney, NSW, Australia.
  • Heim MH; Department of Gastroenterology, University Hospital, Basel, Switzerland.
  • Malinverni R; Pourtalès Hospital, Neuchâtel, Switzerland.
  • Moradpour D; Division of Gastroenterology and Hepatology, University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Müllhaupt B; Division of Gastroenterology and Hepatology, University Hospital of Zurich, Zurich, Switzerland.
  • Negro F; Division of Clinical Pathology and Division of Gastroenterology and Hepatology, University Hospitals, Geneva, Switzerland.
  • Semela D; Division of Gastroenterology, Canton Hospital, St. Gall, Switzerland.
  • Semmo N; Hepatology, Department of clinical Research, University of Bern, Bern, Switzerland.
  • Villard J; Transplantation Immunology Unit, Division of Immunology and Allergy, Department Medicine and Laboratory Medicine, Geneva University Hospital and Medical School, Geneva, Switzerland.
  • Bibert S; Infectious Diseases Service, Department of Medicine, University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Bochud PY; Infectious Diseases Service, Department of Medicine, University Hospital and University of Lausanne, Lausanne, Switzerland.
Liver Int ; 37(10): 1431-1445, 2017 10.
Article em En | MEDLINE | ID: mdl-28261910
ABSTRACT
While hepatitis C exemplifies the role of host genetics in infectious diseases outcomes, there is no comprehensive overview of polymorphisms influencing spontaneous and/or treatment-induced hepatitis C virus clearance. We performed a systematic review and meta-analysis of host polymorphisms associated with these phenotypes. Literature search was conducted using combinations of keywords in three databases. Studies were reviewed and relevant data systematically extracted for subsequent meta-analyses. Polymorphisms from candidate gene studies were tested in two cohorts of HCV-infected patients with available genomic data. The literature search yielded 8'294 citations, among which 262 studies were selected. In the meta-analysis of 27 HLA studies, the most significant associations with spontaneous hepatitis C virus clearance included DQB1*02, DQB1*03, DRB1*04 and DRB1*11. In the meta-analysis of 16 studies of KIR genes and their HLA-ligands, KIR2DS3 was associated with both spontaneous and treatment-induced clearance, and the HLA-C2 ligand with failure to spontaneously clear the virus. In a pooled analysis of 105 candidate genes and two genome-wide association studies, we observed associations of single nucleotide polymorphisms from nine genes (EIF2AK2, IFNAR2, ITPA, MBL2, MX1, OASL, SPP1, TGFB1, TNK2) with response to interferon-based therapy. Meta-analysis of 141 studies confirmed the association of IFNL3/4 polymorphisms with spontaneous and treatment-induced hepatitis C virus clearance, even in previously underpowered groups, such as hepatitis C virus genotypes 2/3-infected patients. This study may contribute to a better understanding of hepatitis C virus immunopathogenesis and highlights the complex role of host genetics in hepatitis C virus clearance.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite C / Hepacivirus / Polimorfismo de Nucleotídeo Único / Receptores KIR / Antígenos HLA Tipo de estudo: Diagnostic_studies / Etiology_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite C / Hepacivirus / Polimorfismo de Nucleotídeo Único / Receptores KIR / Antígenos HLA Tipo de estudo: Diagnostic_studies / Etiology_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article